Dr. Reddy’s Laboratories Ltd.’s Revenues Cross $2 Billion Milestone* in FY12

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced its audited consolidated financial results for the quarter and full year ended March 31, 2012 under International Financial Reporting Standards (IFRS).
MORE ON THIS TOPIC